The Journal of Eye Disorders and Therapy is a peer-reviewed, open-access scholarly journal dedicated to advancing the understanding, diagnosis, prevention, and treatment of a wide range of ocular conditions and visual system disorders. The journal serves as a vital platform for ophthalmologists, optometrists, vision scientists, clinical researchers, and healthcare professionals to publish high-quality, original research and reviews that contribute to the global knowledge of eye health and vision care.
Our journal covers all aspects of eye-related diseases, including but not limited to glaucoma, cataract, age-related macular degeneration, diabetic retinopathy, retinal disorders, corneal diseases, refractive errors, uveitis, ocular infections, trauma, and neuro-ophthalmological conditions. We also welcome articles related to innovative diagnostic tools, surgical advancements, emerging therapies, gene therapy, stem cell approaches, pharmacological interventions, and public health strategies addressing vision impairment and blindness.
This Journal commenced publication in 2024, adopts an online publication format. With a frequency of two issues per year, the journal ensures a rigorous review process to uphold the utmost standards of quality and relevance in its published content. By allowing for longer intervals between issues, the journal can effectively address emerging trends, challenges, and innovations in healthcare and advanced nursing. This approach contributes significantly to the advancement of the field by providing practitioners and researchers with valuable insights and evidence-based knowledge.
Authors can submit manuscripts as an email attachment to the Editorial Office at eyedisorders@scitechjournals.org or submit the manuscript online at Journal of Eye Disorders and Therapy
The scope of the journal includes refractive errors, cataracts, glaucoma, diabetic retinopathy, macular degeneration, corneal diseases, ocular infections, pediatric eye disorders, and neuro-ophthalmology. It also addresses innovations in surgical techniques, emerging therapeutic interventions, gene therapy, regenerative medicine, and the application of artificial intelligence in ophthalmic care.
